Quark Pharmaceuticals
14 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery (NCT04654221) | Quark Pharmaceuticals | 2020-02-21 |
| QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery (NCT03510897) | Quark Pharmaceuticals | 2018-06-29 |
Track Quark Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.